SAN DIEGO, Feb. 20, 2018 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered national news coverage on TheStreet.com – one of the top 20 globally ranked business news sites.
A February 15, 2018, article on The Street website entitled “Should You Bet on PotCoin, DopeCoin or Other Marijuana Cryptocurrencies?” quotes Medical Marijuana, Inc.’s CEO Dr. Stuart Titus stating, “The cannabis futures market might be the largest futures market in the world.” Dr. Titus is also quoted talking about how there is potential for cannabis to be traded as both a commodity and an asset-based security.
This leading financial news website, which boasts an audience of over 8 billion global monthly views, is a globally trusted source for news, analysis and information on the financial markets, economy, sector trends, investment and financial planning.
“I’m pleased to be featured in this prominent publication talking about the future of cannabis and new financial opportunities within the industry,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “The business of cannabis is only in its infancy and we expect it to grow exponentially over the next five years.”
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer CMW Media